Antheia Appoints Dr. Chris Savile as VP of BD and Partnerships
19 Mar 2026 //
PR NEWSWIRE
Antheia Expands Biomap-Consortium Project, Securing $9M
04 Mar 2026 //
PR NEWSWIRE
Antheia links with TAPI to scale biosynthetic drug ingredients
21 Nov 2025 //
PRESS RELEASE
Antheia Achieves First Delivery Of Thebaine
29 Oct 2024 //
PR NEWSWIRE
ANANDA And UCLA Start Trial For Nantheia™ ATL5
22 Oct 2024 //
BUSINESSWIRE
ANANDA Scientific Announces Trial For Nantheia™ ATL5 In Opioid Use
15 Oct 2024 //
BUSINESSWIRE
Antheia Secures Funding For Domestic Pharma Ingredient Production
19 Jul 2024 //
PR NEWSWIRE
Antheia and Olon Continue Partnership for Biomanufacturing Antheia™s Pipeline
13 Mar 2024 //
GLOBENEWSWIRE
Antheia Achieves Major Commercial Milestone
24 Aug 2023 //
PR NEWSWIRE
Antheia Appoints Richard Sherwin as Head of Commercialization
17 Aug 2023 //
PR NEWSWIRE
Antheia plans to construct pilot plant facility for biomanufacturing
20 Jul 2022 //
PMM
Antheia Receives $40 million in Venture Debt Financing
23 Jun 2022 //
CONTRACTPHARMA
Antheia Appoints Zack McGahey as Chief Operating Officer
18 Nov 2021 //
PRNEWSWIRE
Antheia locks in partnership with synthetic biology giant Ginkgo
12 Aug 2021 //
ENDPTS

Market Place
Sourcing Support